永安药业: 2024年年度股东会决议公告

Meeting Overview - The shareholder meeting of Yong'an Pharmaceutical Co., Ltd. was held on June 24, 2025, with both on-site and online voting options available [1] - A total of 561 shareholders participated, representing 78,237,116 shares, which is 27.0581% of the total voting shares [1] Proposal Review and Voting Results - The following proposals were reviewed and approved during the meeting: - The 2024 Board of Directors Work Report was approved with 99.8300% in favor [2] - The 2024 Supervisory Board Work Report was approved with 99.8328% in favor [2] - The 2024 Annual Report and its summary were approved with 99.8855% in favor [3] - The 2024 Financial Settlement Report was approved with 99.8828% in favor [4] - The 2024 Profit Distribution Plan was approved with 99.8212% in favor [5] - The reappointment of the accounting firm was approved with 99.8598% in favor [6] - The proposal for using self-owned funds for entrusted financial management was approved with 99.8250% in favor [6] Small Shareholder Voting - Small shareholders also participated in the voting, with the following results: - For the 2024 Board of Directors Work Report, 12,607,582 shares were in favor, representing 0.5949% of the small shareholders' voting rights [2] - For the 2024 Supervisory Board Work Report, 12,609,782 shares were in favor, representing 0.5753% of the small shareholders' voting rights [3] - For the 2024 Annual Report, 12,650,982 shares were in favor, representing 0.2527% of the small shareholders' voting rights [4] - For the 2024 Financial Settlement Report, 12,648,882 shares were in favor, representing 0.2363% of the small shareholders' voting rights [5] - For the 2024 Profit Distribution Plan, 12,600,682 shares were in favor, representing 0.2865% of the small shareholders' voting rights [6] - For the reappointment of the accounting firm, 12,630,882 shares were in favor, representing 0.3799% of the small shareholders' voting rights [6] - For the entrusted financial management proposal, 12,603,682 shares were in favor, representing 0.4961% of the small shareholders' voting rights [6] Legal Verification - The meeting was witnessed by lawyers from Shanghai Jintiancheng (Wuhan) Law Firm, confirming that the meeting's procedures and voting results were in compliance with relevant laws and regulations [6]